| Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? K Blennow, A Wallin, H Ågren, C Spenger, J Siegfried, E Vanmechelen Molecular and chemical neuropathology 26, 231-245, 1995 | 979 | 1995 |
| Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF F Hulstaert, K Blennow, A Ivanoiu, HC Schoonderwaldt, ... Neurology 52 (8), 1555-1555, 1999 | 977 | 1999 |
| Cerebrospinal fluid β-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease N Andreasen, C Hesse, P Davidsson, L Minthon, A Wallin, B Winblad, ... Archives of neurology 56 (6), 673-680, 1999 | 809 | 1999 |
| Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice N Andreasen, L Minthon, P Davidsson, E Vanmechelen, H Vanderstichele, ... Archives of neurology 58 (3), 373-379, 2001 | 798 | 2001 |
| Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 M Goedert, R Jakes, E Vanmechelen Neuroscience letters 189 (3), 167-170, 1995 | 655 | 1995 |
| Detection of proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme‐linked immunosorbent assay M Vandermeeren, M Mercken, E Vanmechelen, J Six, A Van de Voorde, ... Journal of neurochemistry 61 (5), 1828-1834, 1993 | 645 | 1993 |
| Measurement of phosphorylated tau epitopes in the differential diagnosisof Alzheimer disease: a comparative cerebrospinal fluid study H Hampel, K Buerger, R Zinkowski, SJ Teipel, A Goernitz, N Andreasen, ... Archives of general psychiatry 61 (1), 95-102, 2004 | 618 | 2004 |
| The β-secretase BACE1 in Alzheimer’s disease H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ... Biological psychiatry 89 (8), 745-756, 2021 | 601 | 2021 |
| Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization E Vanmechelen, H Vanderstichele, P Davidsson, E Van Kerschaver, ... Neuroscience letters 285 (1), 49-52, 2000 | 584 | 2000 |
| Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke C Hesse, L Rosengren, N Andreasen, P Davidsson, H Vanderstichele, ... Neuroscience letters 297 (3), 187-190, 2001 | 569 | 2001 |
| A practical guide to immunoassay method validation U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ... Frontiers in neurology 6, 179, 2015 | 554 | 2015 |
| Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values M Sjogren, H Vanderstichele, H Ågren, O Zachrisson, M Edsbagge, ... Clinical chemistry 47 (10), 1776-1781, 2001 | 542 | 2001 |
| Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people G De Meyer, F Shapiro, H Vanderstichele, E Vanmechelen, ... Archives of neurology 67 (8), 949-956, 2010 | 538 | 2010 |
| Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology NJ Ashton, TA Pascoal, TK Karikari, AL Benedet, J Lantero-Rodriguez, ... Acta neuropathologica 141, 709-724, 2021 | 518 | 2021 |
| Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ... Archives of neurology 69 (11), 1445-1452, 2012 | 510 | 2012 |
| Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology A Olsson, H VANDERSticHELE, N Andreasen, G De Meyer, A WALLiN, ... Clinical chemistry 51 (2), 336-345, 2005 | 504 | 2005 |
| Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein M Goedert, R Jakes, RA Crowther, P Cohen, E Vanmechelen, ... Biochemical Journal 301 (3), 871-877, 1994 | 451 | 1994 |
| CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease K Blennow, E Vanmechelen, H Hampel Molecular neurobiology 24, 87-97, 2001 | 397 | 2001 |
| Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma H Vanderstichele, EV Kerschaver, C Hesse, P Davidsson, MA Buyse, ... Amyloid 7 (4), 245-258, 2000 | 397 | 2000 |
| Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment O Hansson, H Zetterberg, E Vanmechelen, H Vanderstichele, ... Neurobiology of aging 31 (3), 357-367, 2010 | 367 | 2010 |
Sebastiaan EngelborghsFull Professor Vrije Universiteit Brussel & University of AntwerpВерификована је имејл адреса на uantwerpen.be